These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 22322254)

  • 1. Cancer biomarkers: selecting the right drug for the right patient.
    Kelloff GJ; Sigman CC
    Nat Rev Drug Discov; 2012 Feb; 11(3):201-14. PubMed ID: 22322254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker strategy in lung cancer.
    Esencay M; Watson A; Mukherjee K; Hanicq D; Gubernick SI
    Nat Rev Drug Discov; 2018 Jan; 17(1):13-14. PubMed ID: 28959953
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies in functional proteomics: Unveiling the pathways to precision oncology.
    Favicchio R; Thepaut C; Zhang H; Arends R; Stebbing J; Giamas G
    Cancer Lett; 2016 Nov; 382(1):86-94. PubMed ID: 26850375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steps forward for cancer precision medicine.
    Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
    Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Medicine.
    Khatri VP; Petrelli NJ
    Surg Oncol Clin N Am; 2020 Jan; 29(1):xv-xvi. PubMed ID: 31757318
    [No Abstract]   [Full Text] [Related]  

  • 6. Precision Medicine in Pediatric Oncology.
    Vo KT; Parsons DW; Seibel NL
    Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges with biomarkers in cancer drug discovery and development.
    Ileana Dumbrava E; Meric-Bernstam F; Yap TA
    Expert Opin Drug Discov; 2018 Aug; 13(8):685-690. PubMed ID: 29792354
    [No Abstract]   [Full Text] [Related]  

  • 8. The Future of Precision Oncology for the Treatment of Solid Tumors.
    Klute KA
    Clin Pharmacol Ther; 2020 Sep; 108(3):416-418. PubMed ID: 31983061
    [No Abstract]   [Full Text] [Related]  

  • 9. The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery.
    El Bairi K; Atanasov AG; Amrani M; Afqir S
    Biomed Pharmacother; 2019 Jan; 109():2492-2498. PubMed ID: 30551510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing cancer drug development through precision medicine and innovative designs.
    Zhang W; Wang J; Menon S
    J Biopharm Stat; 2018; 28(2):229-244. PubMed ID: 29173004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paul Workman: Drugging the Cancer Genome.
    Trends Cancer; 2016 Oct; 2(10):544-548. PubMed ID: 27904887
    [No Abstract]   [Full Text] [Related]  

  • 13. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
    Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
    Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
    [No Abstract]   [Full Text] [Related]  

  • 14. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 15. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of predictive biomarkers in oncology drug development.
    Jørgensen JT
    Expert Rev Mol Diagn; 2016 Aug; 16(8):807-9. PubMed ID: 27282189
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer cell senescence: a new frontier in drug development.
    Cairney CJ; Bilsland AE; Evans TR; Roffey J; Bennett DC; Narita M; Torrance CJ; Keith WN
    Drug Discov Today; 2012 Mar; 17(5-6):269-76. PubMed ID: 22314100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 19. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
    Beer PA; Cooke SL; Chang DK; Biankin AV
    Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210
    [No Abstract]   [Full Text] [Related]  

  • 20. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.